Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.
about
Hematopoietic lineage cell-specific protein 1 immunoreactivity indicates an increased risk of poor overall survival in patients with ovarian carcinoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Hematopoietic lineage cell-spe ...... tients with ovarian carcinoma.
@en
Hematopoietic lineage cell-spe ...... tients with ovarian carcinoma.
@nl
type
label
Hematopoietic lineage cell-spe ...... tients with ovarian carcinoma.
@en
Hematopoietic lineage cell-spe ...... tients with ovarian carcinoma.
@nl
prefLabel
Hematopoietic lineage cell-spe ...... tients with ovarian carcinoma.
@en
Hematopoietic lineage cell-spe ...... tients with ovarian carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Hematopoietic lineage cell-spe ...... tients with ovarian carcinoma.
@en
P2093
Fumitaka Kikkawa
Hiroaki Kajiyama
Kiyosumi Shibata
Takeshi Senga
Wenting Liu
Yoshihiro Koya
P2860
P304
P356
10.3892/OL.2018.8493
P577
2018-04-13T00:00:00Z